
(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)
PDB | Ligand | Drug | Indication | Macromolecule/ Organism |
Pfam | Binding_Interfaces (View) | Details |
---|---|---|---|---|---|---|---|
4pjv | 2YQ | Talazoparib (DB11760) | Talazoparib is a poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer. | POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens) | PARP | ||
4tvj | 09L | Olaparib (DB09074) | Olaparib is a chemotherapeutic agent used to treat recurrent or advanced ovarian cancer and metastatic breast cancer in patients with specific mutations and prior history of chemotherapy. | POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens) | PARP | ||
5ds3 | 09L | Olaparib (DB09074) | Olaparib is a chemotherapeutic agent used to treat recurrent or advanced ovarian cancer and metastatic breast cancer in patients with specific mutations and prior history of chemotherapy. | POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens) | PARP | ||
5ha9 | TP0 | Amitriptyline (DB00321) | Amitriptyline is a tricyclic antidepressant indicated in the treatment of depressive illness, either endogenous or psychotic, and to relieve depression associated anxiety. | POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens) | PARPPARP_reg | ||
6vkk | RPB | Rucaparib (DB12332) | Rucaparib is an anti-cancer agent used to treat recurrent ovarian, fallopian tube, or peritoneal cancer. | POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens) | PARPPARP_reg | ||
7kk3 | 2YQ | Talazoparib (DB11760) | Talazoparib is a poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer. | POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens) | PARPPARP_reg | ||
7kk4 | 09L | Olaparib (DB09074) | Olaparib is a chemotherapeutic agent used to treat recurrent or advanced ovarian cancer and metastatic breast cancer in patients with specific mutations and prior history of chemotherapy. | POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens) | PARPPARP_reg | ||
7kk5 | 3JD | Niraparib (DB11793) | Niraparib is a poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy. | POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens) | PARPPARP_reg | ||
7kkn | 2YQ | Talazoparib (DB11760) | Talazoparib is a poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer. | POLY [ADP-RIBOSE] POLYMERASE (Homo sapiens) | PARP | ||
7kko | 09L | Olaparib (DB09074) | Olaparib is a chemotherapeutic agent used to treat recurrent or advanced ovarian cancer and metastatic breast cancer in patients with specific mutations and prior history of chemotherapy. | POLY [ADP-RIBOSE] POLYMERASE (Homo sapiens) | PARP | ||
7kkp | 3JD | Niraparib (DB11793) | Niraparib is a poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy. | POLY [ADP-RIBOSE] POLYMERASE (Homo sapiens) | PARP | ||
PDB | Ligand | Drug | Indication | Macromolecule/ Organism |
Pfam | Binding_Interfaces (View) | Details |